Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Filings indexed 1,210 across all filing types
Latest filing 2016-03-18 Remuneration Information
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Remuneration Information 2016
Remuneration Information Classification · 99% confidence The document is titled "Selskabsmeddelelse nr. 15/2016" (Company Announcement No. 15/2016) and explicitly states its purpose is "Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer" (Reporting of management's transactions with ALK-Abelló A/S' B-shares and related securities). It details the granting of stock options and conditional shares to members of the executive management ('direktionsmedlem'). This content directly corresponds to the definition of Director's Dealing (insider trades/transactions by executives). Therefore, the correct classification is DIRS.
2016-03-18 English
Indberetning af ledelsens transaktioner med ALK-Abelló A/S’ B-aktier og til-knyttede værdipapirer
Director's Dealing Classification · 91% confidence The document is an announcement under Danish securities trading law (§ 28a) detailing share‐based transactions (stock options and conditional shares) granted to individual board/executive members of ALK-Abelló A/S. This fits the definition of Director’s Dealing, which covers insider transactions by directors and executives. Therefore, it should be classified as DIRS.
2016-03-18 Danish
Indberetning af ledelsens transaktioner med ALK-Abelló A/S’ B-aktier og til-knyttede værdipapirer
Director's Dealing Classification · 100% confidence The document is a formal notification of transactions involving company shares and share options by members of the Board of Management. It explicitly references 'Management's transactions' and provides a table detailing the allotment of share options and conditional shares to specific executives. This aligns perfectly with the definition of 'Director's Dealing' (DIRS), which covers reports of personal share transactions or incentive allotments by company directors and executives.
2016-03-18 English
Remuneration Information 2016
Remuneration Information Classification · 99% confidence The document details the decision by the Board of Directors to grant stock options (aktieoptioner) and conditional shares (betingede aktier) to management and key employees, referencing guidelines approved at the General Meeting. This concerns executive compensation and capital structure incentives. This type of announcement, detailing specific remuneration plans and their valuation, aligns most closely with Remuneration Information (DEF 14A) or potentially Capital/Financing Update (CAP) due to the issuance of options/shares. However, since the core subject is the structure and award of incentive compensation (options and restricted stock), DEF 14A (Remuneration Information) is the most precise fit, even though DEF 14A often relates to proxy statements. Given the options, 'DEF 14A' covers executive compensation details best. If this were purely about a general capital change, 'SHA' might apply, but the focus is on employee incentives. Since the document is a specific announcement about incentive awards, and not a full proxy statement, 'DEF 14A' is chosen as the best fit among the provided codes for compensation details.
2016-03-18 Danish
Remuneration Information 2016
Remuneration Information Classification · 99% confidence The document is titled "Selskabsmeddelelse nr. 14/2016" (Company Announcement No. 14/2016) and details the granting of stock options and conditional shares to management and key employees. This type of announcement concerns executive compensation and insider transactions related to equity incentives. While it touches upon management (MANG) and potentially director dealings (DIRS), the core subject is the structure and allocation of incentive compensation, which is most closely related to Remuneration Information (DEF 14A) or, given its nature as a specific corporate action announcement, potentially a general Regulatory Filing (RNS). Since it is a specific announcement about compensation/incentives rather than the full remuneration report (DEF 14A), and it is a formal company announcement, RNS is a strong candidate. However, the content is highly specific to executive compensation structure, which aligns closely with the intent behind DEF 14A (Remuneration Information). Given the options, and recognizing this is a specific announcement about incentive awards rather than a general regulatory notice, I will classify it based on the subject matter: compensation/incentives. Since DEF 14A is defined as 'Report detailing compensation for top executives and directors,' and this is an announcement detailing the *granting* of compensation instruments, it fits best under the scope of compensation disclosure. If it were a director's personal trade, it would be DIRS. Since it is the company granting the incentives, DEF 14A is the most appropriate fit among the specific codes, although RNS is a possible fallback if the specific compensation code is deemed too narrow for an announcement of a grant. I will select DEF 14A as the primary classification based on the subject matter (incentive compensation structure).
2016-03-18 English
Tildeling af aktieoptioner og betingede aktier til direktion og ledende medarbejdere
Remuneration Information Classification · 95% confidence The document is a company release detailing the grant of share options and conditional shares to members of the Board of Management and key employees. This type of disclosure regarding executive and employee compensation plans, specifically incentive programs, falls under the category of Remuneration Information (DEF 14A). While it mentions the Board of Management, it is specifically focused on the details of the incentive compensation scheme rather than a simple change in personnel.
2016-03-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.